FibroBiologics, Inc.
FBLG
$1.06
-$0.09-7.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.14M | -18.68M | -18.65M | -18.50M | -13.22M |
| Total Depreciation and Amortization | 863.00K | 908.00K | 832.00K | 751.00K | 663.00K |
| Total Amortization of Deferred Charges | 0.00 | 625.00K | 625.00K | 625.00K | 625.00K |
| Total Other Non-Cash Items | 4.02M | 3.66M | 4.11M | 3.08M | -646.00K |
| Change in Net Operating Assets | -1.53M | -2.00M | -3.31M | -2.26M | -2.36M |
| Cash from Operations | -14.79M | -15.48M | -16.39M | -16.30M | -14.94M |
| Capital Expenditure | -6.00K | -219.00K | -262.00K | -361.00K | -366.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -219.00K | -262.00K | -361.00K | -366.00K |
| Total Debt Issued | 327.00K | 4.70M | 4.38M | 13.78M | 13.78M |
| Total Debt Repaid | -3.60M | -3.48M | -3.40M | -115.00K | -287.00K |
| Issuance of Common Stock | 10.16M | 7.30M | 6.59M | 45.00K | 4.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.58M | -- | -- | -- | -- |
| Cash from Financing | 9.47M | 8.52M | 7.57M | 13.71M | 18.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.33M | -7.19M | -9.09M | -2.96M | 2.87M |